To provide an antitrust exemption for medical self-regulatory entities when engaged in standard setting and enforcement activities designed to promote the quality of care, and for other purposes.

Summary

Bars the recovery of damages, interest, costs, or attorney fees under the Clayton Act or similar State laws from any medical self-regulatory entity as a result of standard setting or enforcement activities designed to promote the quality of health care.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 5 January 1993

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 5 January 1993

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 5 January 1993

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.